On December 05, 2022, Vimedimex Medi – Pharma Joint Stock Company announces the Resolution of the extraordinary general shareholders’ meeting (EGM)to approve the following contents:

1. The AGM approved to the amendment, supplement of the Articles of Association.

2. The AGM approved to the amendment, supplement of the Internal corporate governance regulation.
3. The AGM approved to the amendment, supplement of the BOD activities regulation.
4. The AGM approved to the amendment, supplement of the BOS activities regulation.
5. The AGM approved operating model business model on CEVPharma international E-Commerce Exchange.
6. The AGM approved to the selection Cermed GmbH strategic investor.
7. The AGM approved the selection the auditor for the financial statements in 2022 - 2025.
8. The AGM approved the stock issuance to raise its charter capital:

-          Stock volume before the issuance: 15,440,268 dongs

-          Expected issuance volume: 3,088,054

-          Stock volume after the issuance: 18,528,322 dongs

-          Price of issuance: VND29,000/share

-          Total value of issuance: VND 89,553,566,000

-          Expected charter capital after the issuance: VND185,283,216,000

-          Implement time: in 2023

-          Purpose of using capital: to supplement working capital for CEVPharma international E-Commerce Exchange.

        9. Approving the resignation & election of members to the Board of Directors and another member to the Supervisory Board in the term 2022-2027:

-          The resignation of members to the Board of Directors:

Mr. Tran Dinh Huynh

Mrs. To Thuy Anh

-          The election of members to the Board of Directors:

Mr. Trinh Thanh Giang

Mr. Christian Achlennstedt.

-          The AGM did not approve the resignation letter from Mrs. Pham Thi Thu Thao as a member of the Supervisory Board.